Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Gross Margin (2016 - 2025)

Xtant Medical Holdings has reported Gross Margin over the past 16 years, most recently at 66.13% for Q3 2025.

  • Quarterly Gross Margin rose 776.0% to 66.13% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 62.02% through Sep 2025, up 114.0% year-over-year, with the annual reading at 58.17% for FY2024, 258.0% down from the prior year.
  • Gross Margin was 66.13% for Q3 2025 at Xtant Medical Holdings, down from 68.58% in the prior quarter.
  • Over five years, Gross Margin peaked at 68.58% in Q2 2025 and troughed at 50.85% in Q4 2024.
  • The 5-year median for Gross Margin is 60.97% (2023), against an average of 59.46%.
  • Year-over-year, Gross Margin crashed -1379bps in 2021 and then skyrocketed 776bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 55.15% in 2021, then dropped by -1bps to 54.39% in 2022, then rose by 12bps to 60.97% in 2023, then fell by -17bps to 50.85% in 2024, then skyrocketed by 30bps to 66.13% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Gross Margin are 66.13% (Q3 2025), 68.58% (Q2 2025), and 61.52% (Q1 2025).